Protagonist Therapeutics (PTGX) Interest Expenses (2020)
Protagonist Therapeutics' (PTGX) quarterly Interest Expenses came in at $127000.0 in Q4 2020, up 568.42% quarter-over-quarter from $19000.0 in Q3 2020.
Protagonist Therapeutics (PTGX) Interest Expenses (2020) Analysis & Trends
Protagonist Therapeutics has disclosed Interest Expenses across 1 years of filings, most recently posting $127000.0 for Q4 2020.
- Interest Expenses for Q4 2020 came in at $127000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $127000.0 (down 73.04% YoY), and the FY2020 annual result was $598000.0, up 253.85% from the prior year.
- Interest Expenses came in at $127000.0 for Q4 2020 at Protagonist Therapeutics, up from $19000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $243000.0 in Q1 2020 to a low of $19000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 127,000.00 |
| Dec 31, 2020 | 127,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 209,000.00 |
| Jun 30, 2020 | 209,000.00 |
| Mar 31, 2020 | 243,000.00 |
| Mar 31, 2020 | 243,000.00 |